Clicky

Certified Solvency ii Training for the countries of the EEA
Certified Solvency ii Training for countries outside the EEA
Own Risk and Solvency Assessment (ORSA)
Solvency and Financial Condition Report
 
 
Member Benefits                                               ►  Certified Solvency ii Training
   ► How to Become a Member                                ► Order Your Certificate Of Membership  
Reading Room                                                   ► Contact Us

Consultation Paper No. 49 - CEIOPS-CP-49/09, 2 July 2009
Draft CEIOPS Advice for Level 2 Implementing Measures on Solvency II:
Standard formula SCR - Article 109 c, Life underwriting risk

3.8 Life catastrophe risk

3.8.1. Explanatory text
Introduction

3.174. Catastrophe risk stems from extreme or irregular events whose effects are not sufficiently captured in the other life underwriting risk sub-modules.

Examples could be a pandemic event or a nuclear explosion.

3.175. This risk is normally treated by using a one-off extreme mortality and/or morbidity rate.

3.176. Catastrophe risk is mainly associated with products (such as term assurance, critical illness or endowment policies) in which a company guarantees to make a single or recurring & periodic series of payments when a policyholder dies or is diagnosed with a specified disease within a pre-agreed period.

Life catastrophe risk in QIS4

3.177. The QIS4 approach to the SCR standard formula included a catastrophe risk sub-module in the life underwriting risk module (section TS.XI.H of the QIS4 Technical Specifications (MARKT/2505/08)).
 
The calculation of the capital requirement for catastrophe risk was a scenario based stress.

The scenario tested was a combination of the following events:

• an absolute 1.5 per mille increase in the rate of policyholders dying over the following year (e.g. from 1.0 per mille to 2.5 per mille)

• an absolute 1.5 per mille increase in the rate of policyholders experiencing morbidity over the following year.
 
Where appropriate, undertakings should assume that one-third of these policyholders experience morbidity for 6 months, one-third for 12 months and one third for 24 months from the time at which the policyholder first becomes sick.

3.178. The following comments were made by QIS4 participants with regard to the catastrophe risk stress:

• An inconsistency was noted between the full and simplified standard SCR approaches for Cat risk: whereas the full approach allows a negative contribution from annuity business, this is not possible under the simplified methodology.

• The "policy by policy" calculation for the assessment of the Life Lapse and Life Cat risk is considered too burdensome for many undertakings.


Calculation of the capital requirement
3.179. QIS4 participants did not comment on the general methodology of the mortality catastrophe stress and CEIOPS has therefore concluded that the approach adopted in QIS4 was suitable.

3.180. Therefore the capital requirement should be calculated as the change in net asset value (assets minus liabilities) following an absolute increase in the rate of policyholders dying over the following year of x per mille.

3.181. With regard to the morbidity catastrophe stress, CEIOPS has considered further the modelling of health catastrophe risk as part of the development of the health underwriting module.
 
There is a wide variety of health products written across Member States and CEIOPS believes that it is not possible to define a single stress which captures the catastrophe risk associated with different products.
 
Therefore a number of pan European catastrophe scenarios will be developed for health business.
 
For further information on this process, please refer to CEIOPS’ advice on non life catastrophe risk.

3.182. In light of the above, CEIOPS proposes to remove the morbidity catastrophe stress from the life underwriting module.
 
However firms will be expected to consider the extent to which any of the health catastrophe stresses are applicable for their business firm and, if so, apply these stresses in addition to the mortality catastrophe stresses defined above.

Correlations between life and health catastrophe risk will be considered in a later paper.

Calibration of the life catastrophe stress

3.183. The QIS4 calibration of the mortality catastrophe stress was supported by a study carried out by Swiss Re14 in 2007 which estimated that the 1 in 200 year pandemic stress for most developed countries is between 1.0 and 1.5 per mille within insured lives.
 
This study was based on a sophisticated epidemiological model.

3.184. However, there are a number of potential weaknesses in this model such as not adequately allowing for the probability of flu jumping across species such as from birds to humans, not allowing for non-influenza pandemics (e.g. AIDS, drug resistant TB, Ebola virus / MRSA / SARS) or other causes of mortality catastrophe such as terrorism or physical catastrophes such as
earthquakes.
 
If these weaknesses were addressed, it is likely that the estimated stress would increase.

3.185. Furthermore, due to sparse historical data on pandemics, there is a significant degree of uncertainty around the calibration of any pandemic model.
 
3.186. We also note that the 1918 flu pandemic, which is the most significant mortality catastrophe for which data is available, gave rise to death levels of above 5 per mille.

3.187. In light of the above, a mortality catastrophe stress constituting an absolute increase of 2.5 per mille is proposed.

3.188. CEIOPS would appreciate stakeholder feedback on the appropriateness and impact of the proposed increase in the mortality catastrophe stress.

Alternative proposal for life catastrophe stress

3.189. The above propoal does not restrict the application of the catastrophe module to (re)insurance obligations which are contingent in mortality i.e. the module may also be applied to (re)insurance obligations, such as annuities, where the increase in mortality leads to a reduction in technical provisions.

3.190. Although this may seem to reflect the economic substance of (re)insurance undertakings' portfolios by allowing for the diversification between different lines of business, there is evidence to suggest that this diversification benefit may not exist in reality. In particular, historic data indicates that primarily young and healthy people died as a result of influenza pandemics.

3.191. CEIOPS is therefore considering the restriction of the mortality catastrophe module to (re)insurance obligations which are contingent on mortality i.e. where an increase in mortality leads to an increase in techncial provisions.

3.192. If this proposal were implemented, CEIOPS believes that it would be reasonable to consider a lower calibration of the mortality catastrophe stress.

3.193. CEIOPS would appreciate stakeholder feedback on whether the alternative proposal could be considered a better reflection of a 1-in-200 year catastrophe stress than the current proposal.

3.7.2. CEIOPS’ advice
Catastrophe risk

3.194. The calculation of the capital requirement for catastrophe risk shall be a scenario based stress.

3.195. The capital requirement shall be calculated as the change in net asset value (assets minus liabilities) following an absolute increase in the rate of policyholders dying over the following year of 2.5 per mille.

 
Life Underwriting Risk:
 
Introduction to Solvency ii Life Underwriting Risk
 
Solvency ii Mortality Risk
 
Solvency ii Longevity Risk
 
Solvency ii Disability Morbidity Risk
 
Solvency ii Life Expense Risk
 
Solvency ii Life Revision Risk
 
Solvency ii Lapse Risk
 
Solvency ii Life Catastrophe Risk